Literature DB >> 2930608

The role of cholesterol-lowering agents in drug-induced rhabdomyolysis and polymyositis.

J A Goldman, A B Fishman, J E Lee, R J Johnson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2930608     DOI： 10.1002/anr.1780320324

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  12 in total

1.  Rhabdomyolysis associated with lovastatin and erythromycin use.

Authors:  D H Spach; J E Bauwens; C D Clark; W G Burke
Journal:  West J Med       Date:  1991-02

Review 2.  Addressing cardiovascular risk beyond low-density lipoprotein cholesterol: the high-density lipoprotein cholesterol story.

Authors:  Emma A Meagher
Journal:  Curr Cardiol Rep       Date:  2004-11       Impact factor: 2.931

Review 3.  Dyslipidemia in patients with chronic and end-stage kidney disease.

Authors:  Jad Omran; Ashraf Al-Dadah; Kevin C Dellsperger
Journal:  Cardiorenal Med       Date:  2013-07-13       Impact factor: 2.041

4.  Lovastatin-associated dermatomyositis.

Authors:  J L Rodriguez-Garcia; M Serrano Commino
Journal:  Postgrad Med J       Date:  1996-11       Impact factor: 2.401

5.  Role of genetics in the prediction of statin-associated muscle symptoms and optimization of statin use and adherence.

Authors:  Liam R Brunham; Steven Baker; Andrew Mammen; G B John Mancini; Robert S Rosenson
Journal:  Cardiovasc Res       Date:  2018-07-01       Impact factor: 10.787

Review 6.  HMG-CoA reductase inhibitors and myotoxicity.

Authors:  M Ucar; T Mjörndal; R Dahlqvist
Journal:  Drug Saf       Date:  2000-06       Impact factor: 5.606

7.  Lovastatin-induced acute rhabdomyolysis.

Authors:  A D Kogan; S Orenstein
Journal:  Postgrad Med J       Date:  1990-04       Impact factor: 2.401

Review 8.  Is statin-induced myositis part of the polymyositis disease spectrum?

Authors:  Jemima Albayda; Andrew L Mammen
Journal:  Curr Rheumatol Rep       Date:  2014-08       Impact factor: 4.592

Review 9.  Effects of HMG-CoA reductase inhibitors on skeletal muscle: are all statins the same?

Authors:  Marc Evans; Alan Rees
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

10.  Statins may aggravate myasthenia gravis.

Authors:  Shin J Oh; Rohit Dhall; Angela Young; Marla B Morgan; Liang Lu; Gwendolyn C Claussen
Journal:  Muscle Nerve       Date:  2008-09       Impact factor: 3.217
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.